Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...

This article reviews the scope, key principles, methodological expectations, and regulatory implications of ICH E20, and ...

The U.S. Food and Drug Administration (FDA) announced a “real-time clinical trials” (RTCT) pilot program to permit agency reviewers to review ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.

Circulating Tumor DNA for Minimal Residual Disease in Colon Cancer: Ready for Prime Time? Patient subtypes included in the regorafenib arm of GBM AGILE were newly diagnosed unmethylated (NDU) and RD ...

An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical studies, the agency said on Monday. To remedy this shortfall, the U.S.

(a) Ramsey interferometry with a GHZ state using parity measurement; (b) Ramsey interferometry with a GHZ state using one-axis twisting interaction-based readout; (c) a Bayesian estimation process ...

New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes Evinova, a global health tech company with ...

Felicione is an independent clinical research scientist and principal investigator. Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising ...

While “unprecedented change” is by now the default description of the artificial intelligence (AI) era, disruption is hardly new. Organizations have long faced technological, economic, and social ...